Micro- and Macrovascular Adaptations in Patients With Peripheral Arterial Disease During Supervised Exercise Therapy

NCT ID: NCT00675402

Last Updated: 2011-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

117 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Given that previous studies demonstrated the feasibility of the required MRI techniques, we propose to study the macro- and microvascular adaptations in PAOD patients undergoing supervised exercise therapy. It is expected to provide valuable insights into the contribution of each vascular mechanism to the rehabilitation and to identify which vascular mechanism fails or is insufficient for a successful rehabilitation. Improvement of future treatment requires the identification of relevant adaptive mechanisms. With this we will provide early noninvasive MRI readout tools to diagnose and monitor the potential rehabilitation during any form of therapy for PAOD that affects the peripheral vasculature.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PAOD (Peripheral Arterial Obstructive Disease)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Patients referred to the vascularsurgeon with complaints of claudication for their first time, will be asked to participate with the study, with respect toward the in- and exclusion criteria.

supervised treadmill exercise program

Intervention Type OTHER

Supervised treadmill therapy consists of a walking exercise on a treadmill under supervision of a physiotherapist, 2-3 times a week. This program is combined with individual walking every other day and the total duration of the program is 6 months. Guided by the painfree walking distance, every month the angle and/or speed of the treadmill will increase. A standardized protocol for this type of therapy is already in use by many physiotherapists in Limburg (Willigendael, 2005).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

supervised treadmill exercise program

Supervised treadmill therapy consists of a walking exercise on a treadmill under supervision of a physiotherapist, 2-3 times a week. This program is combined with individual walking every other day and the total duration of the program is 6 months. Guided by the painfree walking distance, every month the angle and/or speed of the treadmill will increase. A standardized protocol for this type of therapy is already in use by many physiotherapists in Limburg (Willigendael, 2005).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Intermittent claudication according to a positive Rose-Edingburgh questionnaire
* Rest ankle-brachial pressure index (ABPI) \< 0,90 or 10% decline in ABPI after exercise
* Arterial stenosis/occlusion of femoro-popliteal territory according to duplex/MRA measurements
* Able to ondergo exercise therapy

Exclusion Criteria

* Chronic or acute critical ischemia
* Treated by or planned for vascular surgery or percutaneous transluminal angioplasty
* Recent onset \<2 months
* Unable to perform treadmill exercise
* Diabetes mellitus
* Contra-indications for (Gadolinium-enhanced) MRI or thigh cuff inflation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maastricht University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maastricht University Hospital, dep. of Radiology

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

WH Backes, PhD

Role: PRINCIPAL_INVESTIGATOR

Maastricht University Hospital, dep. of Radiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maastricht University Hospital

Maastricht, Limburg, Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bas Versluis

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bas Versluis

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MEC 08-2-032

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.